Počet záznamov: 1
LAK bunky
SYS d015979 LBL 00000cz--a2200000o--4500 005 20250606213149.3 008 920626|||anznnbabn-----------|-a|a------ 040 $b slo $a DNLM $d BA006 065 $a A11.118.637.555.283.500 065 $a A11.118.637.555.567.537.500 065 $a A15.145.229.637.555.283.500 065 $a A15.145.229.637.555.567.537.500 065 $a A15.382.490.555.283.500 065 $a A15.382.490.555.567.537.500 066 $a 01 $c 03 150 $a LAK bunky $x CH $x CL $x CY $x DE $x EN $x IM $x ME $x MI $x PA $x PH $x PS $x RE $x TR $x UL $x VI $2 slo 450 $w v $a LAK Cells $2 eng 450 $w v $a Lymphokine-Activated Killer Cells $2 eng 450 $w v $a lymfokínmi aktivované zabíjačské bunky $2 slo 450 $w v $a lymfokínmi aktivované killer bunky $2 slo 550 $7 sllk_us_auth*d003602 $Y Cytotoxicity, Immunologic $w b $a cytotoxicita imunologická 550 $7 sllk_us_auth*d007376 $Y Interleukin-2 $w p $a interleukín-2 550 $7 sllk_us_auth*d016219 $Y Immunotherapy, Adoptive $w p $a imunoterapia adoptívna 665 $a 90 $2 eng 665 $a Killer Cells, Natural (1982-1989) $2 eng 680 9-
$i Cytolytic lymphocytes with the unique capacity of killing natural killer (NK)-resistant fresh tumor cells. They are INTERLEUKIN-2-activated NK cells that have no MAJOR HISTOCOMPATIBILITY COMPLEX restriction or need for antigen stimulation. LAK cells are used for ADOPTIVE IMMUNOTHERAPY in cancer patients. $2 eng 680 $a if subpopulations are discussed, coordinate IM with LYMPHOCYTE SUBSETS (IM) $2 eng 750 -2
$a Killer Cells, Lymphokine-Activated $2 eng 980 $x M
Počet záznamov: 1